FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/01/100199 [Registered on: 02/01/2026] Trial Registered Prospectively
Last Modified On: 01/01/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Dentistry 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Patients with gum disease receiving nanoparticle infused gel and lycopene gel along with teeth cleaning procedure and its effect on salivary cortisol levels and gum disease parameters. 
Scientific Title of Study   Comparative evaluation of effectiveness of nanoparticle infused gel and lycopene gel as an adjunct to scaling and root planing on salivary cortisol levels at different time interval in stage-III periodontitis- a clinico-biochemical trial 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sanjana Jirafe 
Designation  PhD scholar 
Affiliation  PhD scholar 
Address  212,Department of Periodontology, Government Dental College and Hospital, Nagpur

Nagpur
MAHARASHTRA
440003
India 
Phone  9923905017  
Fax    
Email  adisanju3@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Mangesh Phadnaik 
Designation  Professor and HOD 
Affiliation  PhD guide 
Address  212, Department of Periodontology, Government Dental College and Hospital, Nagpur

Nagpur
MAHARASHTRA
440003
India 
Phone  9422254404  
Fax    
Email  drmbphadnaik@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Sanjana Jirafe 
Designation  PhD scholar 
Affiliation  PhD scholar 
Address  212, Department of Periodontology, Government Dental College and Hospital, Nagpur

Nagpur
MAHARASHTRA
440003
India 
Phone  9923905017  
Fax    
Email  adisanju3@gmail.com  
 
Source of Monetary or Material Support  
infrastructural support: Government Dental College and Hospital, Nagpur 
 
Primary Sponsor  
Name  NIL 
Address  NIL 
Type of Sponsor  Other [NIL] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Sanjana Jirafe  Government Dental College and Hospital, Nagpur  Department of Periodontology
Nagpur
MAHARASHTRA 
9923905017

adisanju3@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  Periodontitis 
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: lycopene gel, Reference: gel, Route: Topical, Dosage Form: Dantamanjan Churna/ Gum Paint, Dose: 1(mg), Frequency: sos, Bhaishajya Kal: , Duration: , anupAna/sahapAna: No, Additional Information:
(2) Medicine Name: 3 Months, Reference: , Route: , Dosage Form: Dantamanjan Churna/ Gum Paint, Dose: (), Frequency: , Bhaishajya Kal: , Duration: , anupAna/sahapAna: No, Additional Information:
(3) Medicine Name: 3 Months, Reference: , Route: , Dosage Form: Dantamanjan Churna/ Gum Paint, Dose: (), Frequency: , Bhaishajya Kal: , Duration: , anupAna/sahapAna: No, Additional Information:
2Comparator Arm (Non Ayurveda)-Scaling and root planing aloneSRP alone
3Intervention ArmDrugOther than Classical(1) Medicine Name: Gold and silver nanoparticle infused gel, Reference: NA, Route: Topical, Dosage Form: Dantamanjan Churna/ Gum Paint, Dose: 5(ml), Frequency: sos, Bhaishajya Kal: , Duration: , anupAna/sahapAna: No, Additional Information:
(2) Medicine Name: 3 Months, Reference: NA, Route: , Dosage Form: Dantamanjan Churna/ Gum Paint, Dose: (), Frequency: , Bhaishajya Kal: , Duration: , anupAna/sahapAna: No, Additional Information:
(3) Medicine Name: 3 Months, Reference: NA, Route: , Dosage Form: Dantamanjan Churna/ Gum Paint, Dose: (), Frequency: , Bhaishajya Kal: , Duration: , anupAna/sahapAna: No, Additional Information:
 
Inclusion Criteria  
Age From  25.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1. Patients with stage III periodontitis
2. Site selected having probing pocket depth of more than or equal to 6mm and Clinical attachment level of more than or equal to 5mm.
3. Age group 25 to 65 years. 
 
ExclusionCriteria 
Details  1. Patients with medical disorders such as cardiovascular or renal disease, poorly controlled
diabetes, liver diseases, malignancy, and radiotherapy.
2. Patients with recent history or presence of acute or chronic infection.
3. Pregnant women or lactating mothers.
4. Inability of the persons to co-operate because of their physical or mental status or daily
routine.
5. Patients who has gone under any antibiotic therapy in previous 6 months.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Pre-numbered or coded identical Containers 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
1. To evaluate an effectiveness of gold and silver nanoparticles infused gel on salivary
cortisol levels.
2. To evaluate an effectiveness of lycopene gel on salivary cortisol levels.
3. To evaluate an effectiveness of SRP alone on salivary cortisol levels.
4. To compare effectiveness of gold and silver nanoparticles infused gel, lycopene gel and
SRP alone on salivary cortisol level 
At baseline, 3 months and 6 months  
 
Secondary Outcome  
Outcome  TimePoints 
1. To evaluate an effectiveness of gold & silver nanoparticles infused gel on Plaque Index,
Gingival Index, Probing Pocket Depth & Clinical Attachment Levels.
2. To evaluate an effectiveness of lycopene gel on Plaque Index, Gingival Index, Probing
Pocket Depth & Clinical Attachment Levels.
3. To evaluate an effectiveness of SRP alone on Plaque Index, Gingival Index, Probing
Pocket Depth & Clinical Attachment Levels.
4. To compare effectiveness of gold & silver nanoparticles infused gel, lycopene gel and
SRP alone on Plaque Index, Gingival Index, Probing Pocket Depth & Clinical
Attachment Levels. 
At baseline, 3 months & 6 months 
 
Target Sample Size   Total Sample Size="90"
Sample Size from India="90" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   02/02/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="3"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Periodontitis is an inflammatory disease of periodontium which includes gum and bone loss. Salivary cortisol levels act as a biomarker for the periodontal disease. Considering antioxidant properties of lycopene and gold and silver nanoparticles, this study will be designed such as to evaluate and compare effectiveness of gold and silver nanoparticle infused gel and lycopene gel as an adjunct to Scaling and Root Planing and Scaling and Root Planing alone on salivary cortisol levels in the treatment of stage III periodontitis.  
Close